NEWS

Neruda Scott (Johnson & Johnson), Bauke Anninga (Innovation Forum), Laura Soucek (Peptomyc) and Emma Kohring (Johnson & Johnson).

Panel of expert judges selects winner from 14 short-listed European start-ups that showed greatest potential for transformative healthcare solutions

Startup Slam sponsor and co-host Johnson & Johnson Innovation recognizes high caliber of entries selected to compete for prestigious award

[…]

Funds will help company reach preclinical validation for lead candidate in glioblastoma – an aggressive and lethal brain tumor – and in other cancer indications.

[…]

 
This second grant in 2 months further supports Peptomyc in its mission to bring novel Myc inhibitors closer to clinical use for cancer treatment.

[…]

This grant represents the first big step forward for the company as it looks for further funding from investors to bring its novel Myc inhibitors closer to clinical application in cancer.

[…]